JF
EWTX icon

Jump Financial’s Edgewise Therapeutics EWTX Stock Holding History

Jump Financial’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-79,915
Closed -$1.98M – 2036
2025
Q4 		$1.98M Sell
79,915
-910
-1% -$18.3K 0.02% 683
2025
Q3 		$1.31M Sell
80,825
-40,880
-34% -$580K 0.02% 896
2025
Q2 		$1.6M Buy
+121,705
New +$1.76M 0.02% 796
2025
Q1 		– Sell
-55,178
Closed -$1.47M – 1704
2024
Q4 		$1.47M Sell
55,178
-76,628
-58% -$2.44M 0.03% 617
2024
Q3 		$3.52M Buy
+131,806
New +$2.62M 0.07% 319
2024
Q1 		– Sell
-47,100
Closed -$515K – 2004
2023
Q4 		$515K Buy
+47,100
New +$331K 0.02% 1049

Other funds holding EWTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Jump Financial's EWTX Position: Q1 2026 in Review

Jump Financial sold out of Edgewise Therapeutics (EWTX) in Q1 2026, closing a stake of 79,915 shares — an estimated $1.98M sold.

Jump Financial first reported a position in EWTX in Q4 2023 and held it in 6 quarters. The position peaked at $3.52M in Q3 2024. 214 funds tracked by Wall St. Rank hold EWTX as of Q1 2026.

  • Jump Financial reported no remaining Edgewise Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Jump Financial sold 79,915 Edgewise Therapeutics shares in Q1 2026, an estimated $1.98M.
  • Jump Financial first reported a position in Edgewise Therapeutics in Q4 2023 and held it in 6 quarters.
  • Jump Financial's Edgewise Therapeutics position peaked at $3.52M in Q3 2024.
  • 214 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.